April 14, 2022
Case Presentation: Temporalis muscle thickness in Primary CNS Lymphoma
Alipi Bonm, M.D., Ph.D.
April 13, 2022
Acute Ischemic Stroke Therapy: New Frontiers
Pooja Khatri, M.D., MSc.
March 24, 2022
Interrogating Racism: How Critical Questions Lead to Equity
Edwin Lindo, J.D.
March 17, 2022
Optical dissection of blood flow through brain capillaries
Andy Y Shih, Ph.D
March 16, 2022
Palliative Care Needs in Post-Acute Stroke
Rachel Schutz, M.D.
March 10, 2022
LATE: TDP-43 in Aging and Alzheimer’s Disease
Caitlin S Latimer, M.D., Ph.D.
March 1, 2022
UW Medicine MS Walk – April 24, 2022
Register and donate today at:
https://mssociety.donordrive.com/team/UWMS
Brain Awareness Week 2022
Wednesday, March 9, 2022
4:00-5:00pm PST
Alzheimer’s disease is a common form of dementia that leads to devastating cognitive and neurological deficits. However, despite affecting an estimated 6.2 million adults in the US alone in 2021, its causes are poorly understood and no effective treatments exist to halt or reverse the neuron death caused by the disease. How the disease starts — and what happens in single cells across the brain as the disease progresses — is similarly unknown. Research at the Allen Institute for Brain Science and elsewhere on the types of cells that make up the human brain has applications for understanding what is happening in Alzheimer’s.
February 10, 2022
How do we make them feel? Quality of Life in Patients with High Grade Glioma
Alyx Porter Umphrey, M.D.
February 9, 2022
New Iatrogenic Neuromuscular Diseases
Marissa Sakoda, M.D.
Previous page Next page